342 related articles for article (PubMed ID: 33593354)
1. The biological function of m6A reader YTHDF2 and its role in human disease.
Wang JY; Lu AQ
Cancer Cell Int; 2021 Feb; 21(1):109. PubMed ID: 33593354
[TBL] [Abstract][Full Text] [Related]
2. m
Chen X; Zhou X; Wang X
Exp Hematol Oncol; 2022 Apr; 11(1):21. PubMed ID: 35382893
[TBL] [Abstract][Full Text] [Related]
3. YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation.
Bai X; Chen J; Zhang W; Zhou S; Dong L; Huang J; He X
Cancer Sci; 2023 Nov; 114(11):4299-4313. PubMed ID: 37700438
[TBL] [Abstract][Full Text] [Related]
4. Decreased
Luo Q; Gao Y; Zhang L; Rao J; Guo Y; Huang Z; Li J
Biomed Res Int; 2020; 2020():5735279. PubMed ID: 32884942
[TBL] [Abstract][Full Text] [Related]
5. Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker.
Liu W; Liu C; You J; Chen Z; Qian C; Lin W; Yu L; Ye L; Zhao L; Zhou R
Front Cell Dev Biol; 2022; 10():954214. PubMed ID: 36120577
[No Abstract] [Full Text] [Related]
6. Downregulation of N
Li J; Meng S; Xu M; Wang S; He L; Xu X; Wang X; Xie L
Oncotarget; 2018 Jan; 9(3):3752-3764. PubMed ID: 29423080
[TBL] [Abstract][Full Text] [Related]
7. YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy.
Xu H; Wang Z; Chen M; Zhao W; Tao T; Ma L; Ni Y; Li W
Cell Biosci; 2021 Jul; 11(1):132. PubMed ID: 34266473
[TBL] [Abstract][Full Text] [Related]
8. Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression.
Liu R; Jia Y; Kong G; He A
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2215-2230. PubMed ID: 35763107
[TBL] [Abstract][Full Text] [Related]
9. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
10. N6-Methyladenosine Promotes TNF mRNA Degradation In CD4+ T Lymphocytes.
van Vroonhoven ECN; Picavet LW; Scholman RC; Sijbers LJPM; Kievit CRE; van den Dungen NAM; Mokry M; Evers A; Lebbink RJ; Mocholi E; Coffer PJ; Calis JJA; Vastert SJ; van Loosdregt J
J Leukoc Biol; 2024 Apr; ():. PubMed ID: 38657004
[TBL] [Abstract][Full Text] [Related]
11. Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.
Dai XY; Shi L; Li Z; Yang HY; Wei JF; Ding Q
Front Oncol; 2021; 11():635329. PubMed ID: 33928028
[TBL] [Abstract][Full Text] [Related]
12. Methyltransferase-like 3 contributes to inflammatory pain by targeting TET1 in YTHDF2-dependent manner.
Pan Z; Zhang Q; Liu X; Zhou H; Jin T; Hao LY; Xie L; Zhang M; Yang XX; Sun ML; Xue ZY; Tao Y; Ye XC; Shen W; Cao JL
Pain; 2021 Jul; 162(7):1960-1976. PubMed ID: 34130310
[TBL] [Abstract][Full Text] [Related]
13. Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinoma.
Nakagawa N; Sonohara F; Tanaka K; Sunagawa Y; Inokawa Y; Takami H; Hayashi M; Yamada S; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
Oncol Lett; 2021 Jul; 22(1):538. PubMed ID: 34084217
[TBL] [Abstract][Full Text] [Related]
14. YTHDF2 promotes mitotic entry and is regulated by cell cycle mediators.
Fei Q; Zou Z; Roundtree IA; Sun HL; He C
PLoS Biol; 2020 Apr; 18(4):e3000664. PubMed ID: 32267835
[TBL] [Abstract][Full Text] [Related]
15. The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function.
Mapperley C; van de Lagemaat LN; Lawson H; Tavosanis A; Paris J; Campos J; Wotherspoon D; Durko J; Sarapuu A; Choe J; Ivanova I; Krause DS; von Kriegsheim A; Much C; Morgan M; Gregory RI; Mead AJ; O'Carroll D; Kranc KR
J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33156926
[TBL] [Abstract][Full Text] [Related]
16. The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I-Mediated Immune Response.
Zhang L; Li Y; Zhou L; Zhou H; Ye L; Ou T; Hong H; Zheng S; Zhou Z; Wu K; Yan Z; Thiery JP; Cui J; Wu S
Cancer Res; 2023 Jun; 83(11):1834-1850. PubMed ID: 36939388
[TBL] [Abstract][Full Text] [Related]
17. YTHDF2 promotes multiple myeloma cell proliferation via STAT5A/MAP2K2/p-ERK axis.
Hua Z; Wei R; Guo M; Lin Z; Yu X; Li X; Gu C; Yang Y
Oncogene; 2022 Mar; 41(10):1482-1491. PubMed ID: 35075244
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma.
Mu Z; Dong D; Sun M; Li L; Wei N; Hu B
Front Oncol; 2020; 10():1566. PubMed ID: 33102202
[TBL] [Abstract][Full Text] [Related]
19. SUMOylation of the m6A reader YTHDF2 by PIAS1 promotes viral RNA decay to restrict EBV replication.
Sugiokto FG; Saiada F; Zhang K; Li R
bioRxiv; 2023 Aug; ():. PubMed ID: 37609256
[TBL] [Abstract][Full Text] [Related]
20. Link Between m6A Modification and Cancers.
Liu ZX; Li LM; Sun HL; Liu SM
Front Bioeng Biotechnol; 2018; 6():89. PubMed ID: 30062093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
